(Received for publication February 10, 1999) Weperformed experiments to screen for neutral sphingomyelinase inhibitors using rat brain microsomes as an enzyme source. Amongmore than 10,000 microbial extracts tested, a mycelial extract of Trichopeziza mollissima SANK 13892 exhibited potent inhibitory activity. The active compound, scyphostatin, was purified by a series of chromatographies.
Scyphostatin inhibited the enzyme with an IC50 value of 1.0fiM.
The breakdown of membrane sphingomyelin (SM) has been shownto play a critical role in intracellular signal transduction. Since Okazaki and Screening procedure sphingomyelin in a final concentration of 2 niM with a specific activity of 31 /iCi/mmol was dried under N2 and mixed with the assay mixture (lOOmM Tris-HCl, pH 7.5, 0.2% Triton X-100, and 5mM magnesium chloride). After incubation at 48°C for 30 minutes, the mixture repeatedly underwent a 15-second probe-type sonication procedure at 20 watts and was then used as a mixed-micelle. The reaction was started by the addition of an enzyme preparation and a microbial extract. It proceeded for 40 minutes at 37°C and was then terminated and extracted by chloroform : methanol (2: 1, v/v) followed by repeated pipetting. After phase separation, the portion of the upper phase containing the enzymatically released phosphocholine was removedand the radioactivity was determined by liquid scintillation counting. N-SMaseactivity was calculated by subtracting the control count run in the condition excluding magnesium. The identity of the product in the upper phase was confirmed by thin layer chromatography as described before14).
Results and Discussion
Taxonomical Studies of Producing Strain SANK13892 was collected in May 1992 in Aomori Prefecture, Japan. The strain was obtained from an ascospore using a single-spore isolation technique. As this discomycete is not identified by cultural features, the dried apothecia were examined for identification.
The mycological properties were as follows (Fig. 1) . Apothecia were up to 0.2mmin diameter, sessile, flat, discoid, greyish orange to yellow, and frilled with hairs. suggested16). Since the present taxonomydoes not accept the generic name Dasyscyphus., it is identified here as Trichopeziza mollissima (Lasch) Fuckel.
Fermentation
A mature slant culture of Trichopeziza mollissima SANK 13892 was inoculated into 500-ml Erlenmyer flasks containing 100 ml of a medium composed of glycerol 5.0%, potato 5.0%, yeast extract 0.5% and malt extract 0.5%. The pH was not adjusted and the medium was supplemented with 0.02% of anti-foaming agent, CB-442. The flask was shaken under aerobic condition for 5 days at 23°C and 200 r.p.m. Twenty-five ml of each seed culture thus obtained was transferred into 2-liter Erlenmyer flasks containing 500 ml of the same medium and shaken for 6 days. Next, 1500ml of the second seed culture was inoculated to a 60-liter tank fermentor containing 30-liter of the same medium and cultivated for 7 days at 23°C. The dissolved oxygen level was maintained around 5p.p.m. by adjusting the agitation rate. As shown in Fig. 2 ., scyphostatin production emerged after most of the glycerol was consumedand the growth rate had started to decline. 80% Acetone Scyphostatin (4.0g)
Isolation
The isolation procedure for scyphostatin is summarized in Fig. 3 . Mycelial cake containing predominant amounts of the active principle was extracted with 80% aqueous acetone. The extract was concentrated in vacuo to removeacetone and the resulting aqueous solution Color reaction Positive to I2 Negative to ninhydrin was extracted twice with ethyl acetate. The ethyl acetate extract was concentrated to a reduced volume and applied on a silica gel column equilibrated with ethyl acetate : acetone, 4 : 1. Since scyphostatin is extremely labile in the solid state, great care was taken to keep the solvent from drying up throughout the isolation procedure. The column was eluted with the same solvent and fractions containing scyphostatin were combined.
By this stage, the purity of the sample inspected by HPLC detection at U.V. 210/mi was more than 85%, a level sufficient to allow biological evaluation. Further purification was accomplished by HPLCwith an ODS column eluted with 80% acetonitrile.
Effluent containing scyphostatin was concentrated to removethe organic solvent and the resulting milky aqueous solution was carefully lyophilized.
Because of the instability of the compound,lyphilization for prolonged periods should also be avoided. The white powder we obtained from this procedure remained unstable even whenstored in a -20°C freezer, and the half-life in such condition was less than 1 month. However, the compound was rather stable in solution and did not decompose when stored in methanol or DMSO solution at -20°C. From the fermentation with the 60-liter tank, 4g of scyphostatin was obtained in pure form. 
Physico-chemical Properties
The physico-chemical properties of scyphostatain are summarized in Table 1 . It was obtained as colorless oil which was soluble in organic solvents such as methanol, acetone, chloroform and ethyl acetate, but insoluble in water. It exhibited strong UVabsorption at 300 /urn, and IR absorption bands at 3,410cm"1 and 1,655cm"1 implied the presence of a hydroxyl group and an amide moiety, respectively. Scyphostatin is not stable in a dry state at room temperature, probably because of the triene moiety. It decomposes to a complex mixture, but it remains stable for months in methanol solution at -20°C. The structure of scyphostatin determined by the spectroscopic method is shown in Fig. 4 . The details have been reported in a separate paper11}.
In Vitro Studies on the Inhibitory Modes of Scyphostatin The preliminary kinetic analyses of scyphostatin were performed using the rat microsome fraction as N-SMase source. The increase in the Kmvalue and decrease in the Vmaxvalue shown in the Lineweaver-Burk plots in Fig.   5A indicate that the inhibition was a mixed-type with respect to sphingomyelin. The Dixon plots shown in Fig.  5B did not match a linear fit and the inhibition seemed to synergistically increase as scyphostatin increased. Thus, the inhibition mechanism appeared to be complex.
At the next possible opportunity, it will be pertinent to perform kinetic analysis to study the inhibition mechanism using the purified N-SMase.
Antimicrobial Activities
Antimicrobial activities of scyphostatin are shownin Table 2 . The compound mainly showed weak activity against Gram-positive bacteria, in contrast to no activity against Gram-negative bacteria. These differences may be due to variable efficiency of scyphostatin penetration into the cell membranesbecause of the compound's bulky side chain.
